India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Icici Ba 321.75 3.39
State Ba 274.70 3.61
Ong Corp 177.15 5.04
Tata Stl 627.00 2.20
I T C Lt 303.40 0.91
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Shilpa Medicare Limited
Shilpa Medicare Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530549NSE:SHILPAMEDBloomberg:SLPA@INReuters:SHME.BO
Market Lot: 1Face Value: 1ISIN Demat: INE790G01031
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
11-Jul-2018       Shilpa Medicare gets EIR for both API facilities at Raichur IRIS
23-Apr-2018       Shilpa Medicare rises post EU-GMP approval for three plants IRIS
31-Jul-2017       Shilpa Medicare concludes USFDA inspection at Telangana facility IRIS
30-May-2017       RBI hikes FII limit in Shilpa Medicare to 40% IRIS
12-Apr-2017       Shilpa Medicare receives EIR from USFDA for Raichur facility IRIS
14-Dec-2016       Shilpa Medicare gains on getting USFDA nod for Capecitabine tablets IRIS
13-Dec-2016       Shilpa Medicare gets USFDA nod for Capecitabine Tablets IRIS
13-Apr-2016       Shilpa Medicare jumps 10% on receiving GMP compliance certificate IRIS
11-Dec-2015       Shilpa Medicare surges after RBI hikes FII limit IRIS
11-Dec-2015       RBI hikes FII investment limit in Shilpa Medicare to 30% IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer